Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
KEM - As of  09/22/24, 04:25:39 AM:   31 Insider Transactions.

Sector: Technology    Industry: Diversified Electronics
Prev Close:$2.99  Avg Vol(3m): 117,108  P/E: 0.00  EPS: -1.17

Email this page to a friend.    Insider Transactions for KEM

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
B 2020-05-11 16:26:01.0 KEMET CORP KEM ARP AMERICAS LP 5.27% view
S 2020-02-12 11:25:39.0 KEMET CORP KEM DIMENSIONAL FUND ADVISORS LP 5.25% view
S 2020-02-12 11:13:22.0 KEMET CORP KEM VANGUARD GROUP INC 6.22% view
B 2020-01-24 12:33:10.0 KEMET CORP KEM GOLDMAN SACHS GROUP INC 5.4% view
B 2020-01-16 15:08:18.0 KEMET CORP KEM ARP AMERICAS LP 5.23% view
S 2020-01-02 14:56:20.0 KEMET CORP KEM Magnetar Financial LLC 4.98% view
B 2019-11-27 16:30:42.0 KEMET CORP KEM Magnetar Financial LLC 5.24% view
S 2019-02-12 18:59:06.0 KEMET CORP KEM RENAISSANCE TECHNOLOGIES LLC 3.99% view
S 2019-02-11 13:55:04.0 KEMET CORP KEM VANGUARD GROUP INC 6.25% view
S 2019-02-08 08:24:36.0 KEMET CORP KEM DIMENSIONAL FUND ADVISORS LP 5.28% view
S 2019-01-31 14:08:13.0 KEMET CORP KEM BlackRock Inc 14.3% view
B 2020-02-14 16:00:12.0 Trillium Therapeutics Inc n/a Sio Capital Management 9.81% view
S 2020-02-14 10:31:27.0 Trillium Therapeutics Inc n/a Matrix Capital Management Company 0.0% view
B 2020-02-13 14:25:14.0 Trillium Therapeutics Inc n/a Growth Equity Opportunities V 2.59% view
B 2020-02-03 16:31:05.0 Trillium Therapeutics Inc n/a Vivo Capital IX 4.9% view
S 2020-01-21 16:52:59.0 Trillium Therapeutics Inc n/a Venrock Healthcare Capital Partners III 9.95% view
B 2019-12-31 16:24:15.0 Trillium Therapeutics Inc n/a MORGAN STANLEY 9.42% view
S 2019-03-04 15:45:01.0 Trillium Therapeutics Inc n/a Growth Equity Opportunities V 0.0% view
S 2019-02-14 14:39:03.0 Trillium Therapeutics Inc n/a Matrix Capital Management Company 3.5% view
B 2019-01-10 15:39:17.0 Trillium Therapeutics Inc n/a AWM Investment Company 5.3% view
B 2018-02-13 16:26:03.0 Trillium Therapeutics Inc n/a BAKER BROS 9.99% view
B 2018-02-06 16:12:22.0 Trillium Therapeutics Inc n/a Growth Equity Opportunities V 2.59% view
S 2017-06-05 16:15:52.0 Trillium Therapeutics Inc n/a Cormorant Asset Management 0.0% view
S 2017-02-13 16:38:51.0 Trillium Therapeutics Inc n/a Mottola Thomas D 7.3% view
B 2017-02-01 17:03:42.0 Trillium Therapeutics Inc n/a JANUS CAPITAL MANAGEMENT LLC 7.5% view
B 2016-02-16 14:41:11.0 Trillium Therapeutics Inc n/a Mottola Thomas D 7.5% view
S 2016-02-16 08:18:30.0 Trillium Therapeutics Inc n/a Flynn James E 2.7% view
B 2016-02-10 16:32:51.0 Trillium Therapeutics Inc n/a Stebbins James Henry DeGraff n/a view
B 2015-04-23 16:20:19.0 Trillium Therapeutics Inc n/a Ridgeback Capital Investments L 6.9% view
B 2015-03-20 11:54:35.0 Trillium Therapeutics Inc n/a Mottola Thomas D n/a view
B 2015-02-23 15:45:33.0 Trillium Therapeutics Inc n/a Opaleye Management Inc 5.19% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.